Yeast-Based Drug Discovery:

The humanized yeast model has emerged as a powerful tool in large-scale screenings directed to target human proteins. The high degree of cellular processes conservation between the yeast Saccharomyces cerevisiae and higher eukaryotes has made this microorganism a valuable cell model to study the pathobiology of several human diseases. The yeast target-based approach can be highly useful in the first-line screening of potentially active compounds to be tested in more complex cell models.

 

 

  • Yeast as a model for human diseases and drug testing

Related Conference of Yeast-Based Drug Discovery:

October 21-22, 2019

6th World Congress and Expo on Applied Microbiology

Rome, Italy
October 23-24, 2019

2nd Global Experts Meeting on Chronic Diseases

Tokyo, Japan
November 06-07, 2019 |

15th Global Summit on Virology and Microbiology

Yokohama | Japan
November 14-15, 2019

23rd World Congress on Biotechnology

| Holiday Inn Amsterdam - Arena Towers Hoogoorddreef | Amsterdam, Netherlands
December 04-05, 2019

Orthodontics and Prosthodontics

Tokyo, Japan
Apr 27-28, 2020

23rd World Nursing Education Conference

Singapore
June 15-16, 2020

49th World Congress on Microbiology

London, UK
June 24-25, 2020

12th International Virology Summit

Rome, Italy

Yeast-Based Drug Discovery: Conference Speakers

Recommended Sessions

Related Journals

Are you interested in